Fingerprint
Dive into the research topics where Evguenia Alexandrova is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Overcoming Ganetespib Resistance to Combat Refractory HER2+ Breast Cancer
Alexandrova, E. (PI), Haley, J. (CoPI), Stopeck, A. (CoPI) & Li, J. (CoPI)
01/1/23 → 12/31/26
Project: Research
-
P63 as a Novel Factor Promoting Pregnancy-Induced HER2-Positive Breast Cancer
Alexandrova, E. (PI)
08/16/16 → 07/31/20
Project: Research
-
Biliverdin reductase B as a new target in breast cancer
Marchenko, N., Nesbitt, N. M., Alexandrova, E., Reisz, J. A., D’Alessandro, A., Suh, J., Uryasev, S., Pennacchia, L. & Bahou, W. F., Dec 2025, In: Breast Cancer Research. 27, 1, 179.Research output: Contribution to journal › Article › peer-review
Open Access -
ΔNp63 Regulates Homeostasis, Stemness, and Suppression of Inflammation in the Adult Epidermis
Eyermann, C. E., Chen, X., Somuncu, O. S., Li, J., Joukov, A. N., Chen, J. & Alexandrova, E. M., Jan 2024, In: Journal of Investigative Dermatology. 144, 1, p. 73-83.e10Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Erratum: Correction: p63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer (Cell death & disease (2021) 12 6 (525))
Eyermann, C. E., Li, J. & Alexandrova, E. M., Jun 30 2021, In: Cell Death and Disease. 12, 7, p. 658 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer
Eyermann, C. E., Haley, J. D. & Alexandrova, E. M., Jan 2021, In: Cell Death and Disease. 12, 1, 126.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
ΔN63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer
Eyermann, C. E., Li, J. & Alexandrova, E. M., Jun 2021, In: Cell Death and Disease. 12, 6, 525.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations